Skip to main content

Kerydin FDA Approval History

FDA Approved: Yes (First approved July 7, 2014)
Brand name: Kerydin
Generic name: tavaborole
Dosage form: Topical Solution
Company: Anacor Pharmaceuticals, Inc.
Treatment for: Onychomycosis, Toenail

Kerydin (tavaborole) is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails.

Development timeline for Kerydin

Jul  8, 2014Approval FDA Approves Kerydin (tavaborole) Topical Solution for Onychomycosis of the Toenails
Oct  3, 2013Anacor Pharmaceuticals Announces FDA Acceptance of Tavaborole NDA for Filing
Jul 29, 2013Anacor Pharmaceuticals Announces That It Has Submitted a New Drug Application to the FDA for Tavaborole

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.